GLN-APREMILAST
GLN-APREMILAST
Approved
DIN Number
02518910
Drug Class
Human
Market Date
Nov 14, 2022
Company
HC
glenmark pharmaceuticals canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02518910
AIG Number0156231002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AA32 APREMILAST
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:24.24.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
APREMILASTActive
Strength: 30 MG
Monograph: APREMILAST